The Q3 2025 13F cluster shows massive institutional buying, but with heavy passive participation and a 45-day lag. Monitor for phase 3 data or regulatory catalysts that could explain the accumulation.
CELC drugs
CELC drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $89.49entry
- T+1 · 5mo ago −1.05%α −1.59% · $88.55
- T+5 · 5mo ago −1.61%α −2.04% · $88.05
- T+20 · 4mo ago +26.84%α +24.95% · $113.51
- T+60 · 2mo ago +6.94%α +2.54% · $95.70
How similar events traded
Executive Summary
8 institutional buyers accumulated $182.2M in CELC (net +$166.0M) while 3 sellers trimmed $14.0M in Q3 2025, a strongly bullish cluster dominated by mega-passive funds and quants (D.E. Shaw new $18.4M, RenTech doubled to $9.6M).
Key Financial Metrics
Institutional Positions
Net institutional flow: $152.0M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| T. Rowe Price | DOUBLED | +3838.9% | $30.0K | $29.0K |
| Wells Fargo | ADD | +48.7% | $1.1M | $903.0K |
| D.E. Shaw | NEW | Not reported | $18.4M | $18.4M |
| UBS | DOUBLED | +910.1% | $42.2M | $41.1M |
| RenTech | DOUBLED | +1387% | $9.6M | $9.4M |
| Morgan Stanley | ADD | +92.9% | $74.7M | $64.3M |
| BofA | DOUBLED | +105.2% | $26.7M | $23.1M |
| Nuveen | DOUBLED | +242.2% | $9.5M | $8.7M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citadel | NEAR_EXIT | -98% | $10.1M | -$9.3M |
| Ameriprise Financial | NEAR_EXIT | -92% | $10.3M | -$7.2M |
| Barclays | TRIM | -33.7% | $1.0K | $2.6M |
Key Facts
- 8 buyers added $166.0M net; 3 sellers cut $14.0M
- D.E. Shaw initiated a $18.4M position (NEW)
- RenTech doubled holdings to $9.6M (+1387%)
- Morgan Stanley added $64.3M (from $10.5M to $74.7M)
- UBS doubled to $42.2M (from $1.1M)
- Citadel and Ameriprise nearly exited, selling $9.3M and $7.2M respectively
- 6 of 8 buyers are mega-passive/quant, weakening the active signal
- Q3 2025 13F data has 45-day lag; current positions may differ
Financial Impact
8 institutions accumulated $182.2M in new holdings (net +$166.0M), while 3 reduced by $14.0M. Net institutional inflow of $152.0M.
Risk Factors
- 13F lag means the cluster may have been partially or fully unwound
- Heavy mega-passive buying may be index rebalancing, not fundamental conviction
- Stock currently trading near $4.3B market cap with 94% analyst buy rating, sentiment may be crowded
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CELC-2025-Q3 |
Track record
26 reports on CELC
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +25.83% at T+60 after the Jul 14, 2026 report. 8 of 12 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $62.58 settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $64.37 settles Nov 23
- Nov 9, 20267d ago Press Release Bullish 5/10 Entry $70.37 to $60.57 ▼ −13.93% −12.23% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $66.79 to $64.37 ▼ −3.62% −6.22% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $69.72 to $67.05 ▼ −3.83% −3.24% vs SPY
- Oct 24, 202623d ago Press Release Bullish 6/10 Entry $65.80 to $69.13 ▲ +5.06% +6.32% vs SPY
- Oct 5, 20266w ago 3 Neutral 2/10 Entry $71.25 to $63.19 ▼ −11.31% −11.17% vs SPY
- Oct 2, 20266w ago 8-K Neutral 2/10 Entry $72.10 to $67.94 ▼ −5.77% −6.93% vs SPY
- Sep 30, 20266w ago 8-K Bullish 6/10 Entry $79.52 to $65.78 ▼ −17.28% −19.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers